Endocrinology SOAP Notes: Complete Documentation Guide

Written by SOAPNoteAI Editorial Team · Updated June 2026

Endocrinology documentation covers a wide spectrum of chronic metabolic and hormonal conditions — from diabetes mellitus and thyroid disease to adrenal disorders and pituitary conditions. Endocrinology SOAP notes must capture complex lab trends, medication adjustments, and long-term monitoring milestones that define outcomes for these chronic conditions.

This guide covers SOAP note documentation for the most common endocrinology encounter types, with detailed templates for diabetes, thyroid disease, PCOS, and adrenal disorders.

Create Your Endocrinology SOAP Note in 2 Minutes

Start with 20 free SOAP notes. No credit card required.

Try Free on Web

Unique Aspects of Endocrinology Documentation

1. Lab Trend Tracking: HbA1c, TSH, lipids, and renal function need to be documented with historical context
2. Medication Titration: Insulin doses, levothyroxine adjustments, and steroid tapers require precise documentation
3. Monitoring Milestones: Screening intervals for diabetes complications must be clearly tracked
4. Shared Goals: ADA, ATA, and Endocrine Society guideline targets should be referenced in the assessment
5. Patient Self-Management: Blood glucose logs, CGM data, self-monitoring technique all belong in the note
6. Comorbidity Complexity: Diabetes + hypertension + hyperlipidemia documentation often overlaps

---

Part 1: Diabetes SOAP Notes

Diabetes mellitus is the most common condition managed by endocrinologists and primary care providers alike. A well-documented diabetes visit captures not just today's glucose but the trajectory of control and completeness of preventive monitoring.

Subjective Section (S) — Diabetes Visit

1. Chief Complaint:

   • Routine diabetes follow-up, specific concerns (hypoglycemia, hyperglycemia, new symptoms)
   • Example: "Here for 3-month diabetes follow-up; reports 3 hypoglycemic episodes in past month"

2. Glycemic Symptom Review:

   • Hyperglycemia: polyuria, polydipsia, blurred vision, fatigue, slow wound healing
   • Hypoglycemia: shakiness, sweating, confusion, loss of consciousness, nocturnal events
   • Example: "Reports polyuria and nocturia x2-3 episodes/night. No hypoglycemic episodes. Blurred vision intermittently."

3. Self-Monitoring Data:

   • Frequency of blood glucose checks
   • Range of readings (fasting, postprandial, bedtime)
   • CGM time-in-range (TIR) and time-below-range (TBR) if applicable

4. Diet and Lifestyle:

   • Dietary adherence, carbohydrate counting, meal timing
   • Physical activity (frequency, type, duration)
   • Weight changes since last visit

5. Medication Adherence:

   • All diabetes medications (oral agents, injectables, insulin)
   • Side effects or barriers to adherence
   • Missed doses, cost concerns

6. Preventive Care Review:

   • Last eye exam, foot exam, dental visit
   • Sick day management history
   • Flu/pneumonia/COVID vaccination status

Objective Section (O) — Diabetes Visit

1. Vital Signs:

   • Blood pressure (target <130/80 for most diabetic patients)
   • Weight and BMI (weight loss trajectory is key for T2DM)
   • Heart rate

2. HbA1c:

   • Current result with date (or note if pending)
   • Previous HbA1c for trend comparison
   • Target HbA1c for this patient (e.g., <7.0%, <8.0% for elderly patients per ADA 2026)

3. Foot Exam:

   • Monofilament testing (10-g Semmes-Weinstein) — document sites tested and results
   • Pedal pulses (dorsalis pedis, posterior tibial — present/absent)
   • Skin integrity (calluses, ulcers, onychomycosis, erythema)
   • Ankle-brachial index (ABI) if peripheral artery disease suspected

4. Laboratory Results:

   • Fasting lipid panel (LDL, HDL, triglycerides)
   • Creatinine and eGFR (kidney function)
   • Urine albumin-to-creatinine ratio (UACR)
   • TSH (annually for T1DM; as clinically indicated for T2DM)
   • Liver function if on thiazolidinediones or statins

5. Physical Exam Relevant to Diabetes:

   • Funduscopic exam if done in office
   • Injection sites for insulin users (document lipodystrophy)
   • Acanthosis nigricans, skin tags (insulin resistance markers)

Assessment Section (A) — Diabetes Visit

1. Type and Duration: Specify diabetes type and years of diagnosis
2. Glycemic Control: Controlled vs. uncontrolled; HbA1c trend
3. Complications Status: Document any present or absent microvascular/macrovascular complications
4. Target Attainment: BP, LDL, HbA1c — at goal or not
5. Other Comorbidities: HTN, hyperlipidemia, CKD, obesity, CAD

Example:

Type 2 diabetes mellitus (E11.65), suboptimally controlled — HbA1c 8.4% (was 7.9% three months ago), worsening trend. No hypoglycemic episodes. Hypertension, controlled (BP 128/78). CKD Stage 2 (eGFR 68), stable. Microalbuminuria (UACR 48 mg/g), newly identified — will initiate SGLT-2 inhibitor for renal protection. Dyslipidemia, on atorvastatin 40 mg — LDL 72 mg/dL, at goal. No neuropathy on foot exam. Eye exam overdue — last 2 years ago.

Plan Section (P) — Diabetes Visit

1. Medication Adjustments:

   • Document specific changes with rationale
   • Example: "Ozempic increased from 0.5 mg to 1.0 mg weekly given adequate tolerance and need for further HbA1c reduction"

2. Monitoring Orders:

   • HbA1c in 3 months (if uncontrolled) or 6 months (if stable)
   • UACR, creatinine/eGFR annually
   • Dilated eye exam referral if overdue
   • Fasting lipid panel (per statin monitoring interval)

3. Referrals:

   • Ophthalmology (annual dilated eye exam)
   • Nephrology (eGFR <30 or complex CKD)
   • Podiatry (neuropathy, foot ulcers, deformity)
   • Diabetes Education (DSMES — Diabetes Self-Management Education and Support)
   • Registered Dietitian (MNT — Medical Nutrition Therapy)

4. Patient Education:

   • Sick day management
   • Hypoglycemia recognition and treatment (15-15 rule)
   • Foot care instructions
   • CGM interpretation (TIR, patterns)

5. Preventive Care:

   • Flu vaccine administered / due
   • Pneumococcal vaccine series status
   • Low-dose aspirin (if indicated)

---

Part 2: Thyroid Disorder SOAP Notes

Hypothyroidism SOAP Note

Subjective (Hypothyroidism): Chief complaint and symptom review: fatigue, cold intolerance, constipation, weight gain, dry skin, hair thinning, brain fog, depression, heavy menstrual periods, muscle cramps. Document levothyroxine dose, time of administration (must be on empty stomach), any changes in timing or co-administration with calcium/iron.

Objective (Hypothyroidism): TSH, free T4 (and free T3 if clinical reason), weight, heart rate (bradycardia in severe hypothyroidism), deep tendon reflexes (delayed relaxation in hypothyroidism), thyroid palpation (goiter size, nodules, tenderness), skin and hair assessment.

Assessment (Hypothyroidism): Document whether the patient is euthyroid (TSH within target range), subclinically hypothyroid (TSH 4.5-10 with normal T4), or overtly hypothyroid. Note the target TSH range for this specific patient (standard: 0.5-2.5 mIU/L; elderly: 1-4 mIU/L; pregnancy: trimester-specific ranges).

Plan (Hypothyroidism): Levothyroxine dose adjustment (if needed), recheck TSH in 6-8 weeks after any dose change, thyroid ultrasound if goiter or nodule present, fine-needle aspiration biopsy referral if nodule >1 cm with suspicious features.

Hyperthyroidism SOAP Note

Key documentation elements for hyperthyroidism:

• Subjective: Heat intolerance, palpitations, tremor, weight loss despite good appetite, diarrhea, anxiety, insomnia, eye symptoms (Graves' — exophthalmos, diplopia)
• Objective: Heart rate (tachycardia), blood pressure, weight loss trend, fine tremor, thyroid exam (smooth diffuse enlargement, bruit in Graves'; tender in thyroiditis), exophthalmos measurement (Hertel), TSH (suppressed <0.1), free T4/T3 (elevated), TRAb antibodies (Graves')
• Assessment: Graves' disease vs. toxic nodular goiter vs. thyroiditis; degree of hyperthyroidism
• Plan: Antithyroid drug therapy (methimazole dose, PTU only in pregnancy first trimester), beta-blocker for symptom control, radioactive iodine (RAI) planning, thyroid surgery referral for large goiter

---

Part 3: Adrenal Disorders SOAP Notes

Adrenal Insufficiency (Primary or Secondary)

Adrenal insufficiency documentation is critical given the life-threatening nature of adrenal crisis. Key elements:

Subjective: Fatigue, weakness, weight loss, salt craving (primary AI), nausea, dizziness, hyperpigmentation history, prior steroid use (secondary AI), illness or stress events, hydrocortisone sick-day dosing history.

Objective: Blood pressure (orthostatic hypotension), heart rate, weight, hyperpigmentation (buccal mucosa, skin creases, scars — primary AI only), sodium/potassium (hyponatremia, hyperkalemia in primary AI), morning cortisol, ACTH stimulation test results.

Plan: Document current hydrocortisone equivalent dose, timing, and sick-day doubling/tripling instructions. Confirm patient has emergency injectable hydrocortisone (Solu-Cortef 100 mg IM kit) and knows when to use it. Medical alert bracelet discussed.

Cushing's Syndrome

Key documentation: 24-hour urine free cortisol, late-night salivary cortisol (x2), 1-mg overnight dexamethasone suppression test results. ACTH level to differentiate ACTH-dependent (pituitary, ectopic) from ACTH-independent (adrenal). Imaging results (pituitary MRI, CT abdomen for adrenal). Symptom burden documentation: moon facies, buffalo hump, striae, hypertension, hyperglycemia, proximal myopathy, easy bruising.

---

Part 4: Polycystic Ovarian Syndrome (PCOS)

PCOS requires documentation across three diagnostic domains (Rotterdam criteria: any 2 of 3):

1. Oligo/Anovulation: Cycle length, frequency, last menstrual period
2. Clinical/Biochemical Hyperandrogenism: Free testosterone, DHEA-S, Ferriman-Gallwey score for hirsutism
3. Polycystic Ovary Morphology: Transvaginal ultrasound findings (follicle count per ovary ≥20, or ovarian volume >10 mL)

Additional labs: SHBG, LH/FSH ratio, TSH (to exclude thyroid disease), prolactin (to exclude hyperprolactinemia), 2-hour oral glucose tolerance test or fasting insulin for metabolic workup, lipid panel.

Treatment plan documentation: lifestyle modification (Mediterranean diet, 150+ min/week exercise), metformin (dose, GI tolerance), combined oral contraceptive (cycle regulation, antiandrogen effect), spironolactone 50-200 mg (hirsutism), fertility treatment referral if desired.

---

AI-Assisted Endocrinology Documentation

How AI Improves Endocrinology SOAP Notes

Endocrinology visits involve reviewing many data points — HbA1c trends, CGM time-in-range, lab histories, and complex medication regimens. AI ambient documentation tools can:

• Capture medication adjustment discussions verbatim and structure them into the plan
• Pull current CGM data referenced during the visit into the appropriate note section
• Structure monitoring milestone documentation (overdue eye exam, UACR, foot exam)
• Document insulin titration rationale clearly

What to Always Verify in AI-Generated Endocrinology Notes

1. HbA1c values and trends — confirm the numbers match your lab results
2. Insulin doses — units are critical; verify basal vs. bolus documentation
3. Thyroid dose — levothyroxine is a narrow therapeutic index drug
4. Monitoring dates — confirm the AI captured the correct date of last eye exam, UACR, etc.
5. Diagnostic codes — verify ICD-10 code specificity (complication status for diabetes)

Structured Verbal Cues for Endocrinology AI Documentation

• "Today's HbA1c is 7.8%, which is an improvement from 8.4% three months ago"
• "I am increasing the glargine from 20 to 24 units at bedtime"
• "TSH has normalized to 1.8 on current levothyroxine dose of 100 micrograms"
• "Patient's dilated eye exam is overdue — last completed two years ago; referral to ophthalmology placed today"

---

Frequently Asked Questions

Frequently Asked Questions

What should be included in the objective section of a diabetes SOAP note?

For diabetes visits, the objective section should include: current weight and BMI, blood pressure (target <130/80 for most T2DM patients), last HbA1c with date and current value if available, fasting glucose from today's labs or most recent self-monitoring log, foot exam findings (monofilament sensation, pulses, skin integrity), dilated eye exam status with date, urine microalbumin/creatinine ratio, lipid panel results, eGFR/creatinine for kidney function, and any hypoglycemic episodes since last visit.

How do I document insulin therapy in endocrinology notes?

Document insulin type (basal: glargine, detemir, degludec; bolus: lispro, aspart, glulisine), dose in units, timing (e.g., 'glargine 24 units subcutaneous at bedtime'), injection site rotation, and self-monitoring results. Include time-in-range (TIR) data if the patient uses continuous glucose monitoring (CGM). Note any dose adjustments with rationale: 'Glargine increased from 20 to 24 units due to fasting glucose consistently >150 mg/dL per log.'

What diagnostic codes are commonly used in endocrinology SOAP notes?

Common endocrinology ICD-10 codes include: E11.9 (Type 2 diabetes without complications), E11.65 (T2DM with hyperglycemia), E10.9 (Type 1 diabetes), E05.90 (Hyperthyroidism, unspecified), E03.9 (Hypothyroidism, unspecified), E27.40 (Adrenocortical insufficiency), E66.01 (Morbid obesity due to excess calories), E28.2 (Polycystic ovarian syndrome), and E23.0 (Hypopituitarism). Always code to the highest level of specificity, including complications.

How do I document thyroid management in endocrinology notes?

Document TSH, free T4, and free T3 results with reference ranges and trends. For hypothyroidism on levothyroxine: record current dose (mcg), last dose adjustment date, symptoms (fatigue, cold intolerance, constipation, weight gain), and exam findings (thyroid size, reflexes, skin/hair). For hyperthyroidism: document tremor, heart rate, exophthalmos, thyroid bruit, TRAb antibody levels, and treatment (methimazole dose, RAI date, surgery history). Note the euthyroid target TSH range for each patient.

What follow-up intervals should be documented for diabetes monitoring?

Per ADA 2026 Standards of Care: HbA1c every 3 months for uncontrolled diabetes, every 6 months when stable. Urine albumin/creatinine ratio annually. Lipid panel annually if on statin, more frequently with dose changes. Dilated eye exam annually (every 2 years if consistently normal). Comprehensive foot exam at every visit; ABI for peripheral vascular disease annually if at risk. Blood pressure at every visit. Thyroid function (TSH) annually for T1DM. Creatinine/eGFR annually. Document dates for all completed studies.

How should I document PCOS in a SOAP note?

For polycystic ovarian syndrome (PCOS) notes, the subjective should cover: menstrual irregularity, hirsutism, acne, weight gain, fertility concerns, and mood changes. Objective: BMI, blood pressure, Ferriman-Gallwey score for hirsutism, acanthosis nigricans, acne grading. Labs: free/total testosterone, DHEA-S, SHBG, LH/FSH ratio, TSH, prolactin, fasting insulin, HbA1c or glucose tolerance. Assessment: Rotterdam criteria fulfilled (2 of 3: oligo/anovulation, hyperandrogenism, polycystic ovaries). Plan: lifestyle modification, metformin, oral contraceptives (for cycle regulation and hyperandrogenism), spironolactone.

Is there an AI tool for endocrinology SOAP note documentation?

Yes, SOAPNoteAI.com provides AI-assisted documentation that understands endocrinology-specific terminology including diabetes management, thyroid disorders, adrenal conditions, and metabolic syndrome. The platform is HIPAA-compliant with a signed Business Associate Agreement (BAA), available on iPhone and iPad, and can reduce documentation time significantly. It captures lab value discussions, medication adjustments, and patient education conversations during or after the visit.